These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 17901525)

  • 1. Early glibenclamide treatment in a clinical newborn with KCNJ11 gene mutation.
    Däublin G; Lorenz-Depiereux B; Strom TM; Blankenstein O; Raile K
    Diabetes Care; 2007 Oct; 30(10):e104. PubMed ID: 17901525
    [No Abstract]   [Full Text] [Related]  

  • 2. Transition from insulin to glyburide in a 4-month-old girl with neonatal diabetes mellitus caused by a mutation in KCNJ11.
    Chan YM; Laffel LM
    Pediatr Diabetes; 2007 Aug; 8(4):235-8. PubMed ID: 17659066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a new KCNJ11 mutation.
    Ješić MM; Ješić MD; Maglajlić S; Sajić S; Necić S
    Diabetes Res Clin Pract; 2011 Jan; 91(1):e1-3. PubMed ID: 21056492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfonylurea-responsive diabetes in childhood.
    Landau Z; Wainstein J; Hanukoglu A; Tuval M; Lavie J; Glaser B
    J Pediatr; 2007 May; 150(5):553-5. PubMed ID: 17452235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diabetes in infants may be treated with sulfonylurea as a replacement for insulin].
    Lauridsen MH; Boesgaard TW; Pedersen OB; Hansen T; Hertz B
    Ugeskr Laeger; 2009 Jun; 171(23):1923-4. PubMed ID: 19500515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KCNJ11 in-frame 15-bp deletion leading to glibenclamide-responsive neonatal diabetes mellitus in a Chinese child.
    Yang W; Wei H; Sang Y
    J Pediatr Endocrinol Metab; 2013; 26(7-8):743-6. PubMed ID: 24266052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfonylrea treatment in permanent neonatal diabetes due to G53D mutation in the KCNJ11 gene: improvement in glycemic control and neurological function.
    Gurgel LC; Crispim F; Noffs MH; Belzunces E; Rahal MA; Moisés RS
    Diabetes Care; 2007 Nov; 30(11):e108. PubMed ID: 17965292
    [No Abstract]   [Full Text] [Related]  

  • 8. Transfer to sulphonylurea therapy in adult subjects with permanent neonatal diabetes due to KCNJ11-activating [corrected] mutations: evidence for improvement in insulin sensitivity.
    Malecki MT; Skupien J; Klupa T; Wanic K; Mlynarski W; Gach A; Solecka I; Sieradzki J
    Diabetes Care; 2007 Jan; 30(1):147-9. PubMed ID: 17192350
    [No Abstract]   [Full Text] [Related]  

  • 9. Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJ11 activating mutation from subcutaneous insulin to oral glyburide.
    Bremer AA; Ranadive S; Lustig RH
    Pediatr Diabetes; 2008 Jun; 9(3 Pt 1):236-9. PubMed ID: 18221420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11.
    Mlynarski W; Tarasov AI; Gach A; Girard CA; Pietrzak I; Zubcevic L; Kusmierek J; Klupa T; Malecki MT; Ashcroft FM
    Nat Clin Pract Neurol; 2007 Nov; 3(11):640-5. PubMed ID: 17982434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain.
    Shimomura K; Hörster F; de Wet H; Flanagan SE; Ellard S; Hattersley AT; Wolf NI; Ashcroft F; Ebinger F
    Neurology; 2007 Sep; 69(13):1342-9. PubMed ID: 17652641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No beta cell desensitisation after a median of 68 months on glibenclamide therapy in patients with KCNJ11-associated permanent neonatal diabetes.
    Iafusco D; Bizzarri C; Cadario F; Pesavento R; Tonini G; Tumini S; Cauvin V; Colombo C; Bonfanti R; Barbetti F
    Diabetologia; 2011 Oct; 54(10):2736-8. PubMed ID: 21822789
    [No Abstract]   [Full Text] [Related]  

  • 13. High-dose glibenclamide can replace insulin therapy despite transitory diarrhea in early-onset diabetes caused by a novel R201L Kir6.2 mutation.
    Codner E; Flanagan S; Ellard S; García H; Hattersley AT
    Diabetes Care; 2005 Mar; 28(3):758-9. PubMed ID: 15735229
    [No Abstract]   [Full Text] [Related]  

  • 14. Transient Neonatal Diabetes due to Kcnj11 Mutation.
    Kochar IP; Kulkarni KP
    Indian Pediatr; 2010 Apr; 47(4):359-60. PubMed ID: 20431170
    [No Abstract]   [Full Text] [Related]  

  • 15. Sulfonylurea treatment in a girl with neonatal diabetes (KCNJ11 R201H) and celiac disease: impact of low compliance to the gluten free diet.
    Delvecchio M; Zecchino C; Faienza MF; Acquafredda A; Barbetti F; Cavallo L
    Diabetes Res Clin Pract; 2009 Jun; 84(3):332-4. PubMed ID: 19345438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient neonatal diabetes mellitus is associated with a recurrent (R201H) KCNJ11 (KIR6.2) mutation.
    Colombo C; Delvecchio M; Zecchino C; Faienza MF; Cavallo L; Barbetti F;
    Diabetologia; 2005 Nov; 48(11):2439-41. PubMed ID: 16205880
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of hyperglycemia in a 7-year-old child diagnosed with neonatal diabetes.
    Hathout E; Mace J; Bell GI; Njølstad PR
    Diabetes Care; 2006 Jun; 29(6):1458. PubMed ID: 16732049
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term efficacy of glibenclamide and sitagliptin therapy in adult patients with KCNJ11 permanent diabetes.
    Sastre J; Luque A; del Val F; Aragonés A; López J
    Diabetes Care; 2014; 37(3):e55-6. PubMed ID: 24558086
    [No Abstract]   [Full Text] [Related]  

  • 19. Islet-specific antibody seroconversion in patients with long duration of permanent neonatal diabetes caused by mutations in the KCNJ11 gene.
    Gach A; Wyka K; Malecki MT; Noczynska A; Skupien J; Nazim J; Szalecki M; Bodalski J; Sieradzki J; Mlynarski W
    Diabetes Care; 2007 Aug; 30(8):2080-2. PubMed ID: 17475937
    [No Abstract]   [Full Text] [Related]  

  • 20. Neonatal diabetes mellitus due to L233F mutation in the KCNJ11 gene.
    Joshi R; Phatarpekar A
    World J Pediatr; 2011 Nov; 7(4):371-2. PubMed ID: 21210267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.